Professional Documents
Culture Documents
Results
The classification of the 773 interval cancers is
shown in Table 1.
Figure 1 shows the distribution of the 200
screen detected cancers. The distribution of the
354 true interval cancers is shown in Figure 2 and
the 122 false negative interval cancers in Figure 3.
The false negative interval cancers for two of the
readers is shown in Figure 4.
Table 1. The number and classification of all interval
cancers at the Warwickshire, Solihull and Coventry
Breast Screening Service
Classification
Number
True
False negative
Occult
Unclassified
Minimal signs
364
122
107
135
45
47.1
15.8
13.8
17.5
5.8
Total
773
100
Figure 1. Distribution of screen detected cancers.
318
of a different distribution on the oblique projection. It can also be seen that false negative and
true interval cancers are of the same distribution
on both the craniocaudal and oblique projections.
Discussion
Our frequency of false negative cancers, 19% of
classifiable cases, is comparable with other series
[11, 12]. The simple user interface allowing the
point and click is very easy to use on a practical
319
View
Significantly
different?
Level of
significance
Craniocaudal
Oblique
Craniocaudal
Oblique
Craniocaudal
Oblique
No
No
No
Yes
Yes
Yes
1%
5%
1%
Figure 6.
Tabars
forbidden
zones i.e. areas that require special
attention. a, Milky way 34 cm
wide parallel to edge of pectoral
muscle; b, no mans land, retroglandular space; c, medial half of
the breast on the craniocaudal projection; d, retroglandular area.
The British Journal of Radiology, April 2001
321
Acknowledgment
Chris Eccles developed the database as part of
his MSc at Coventry University.
References
1. Forrest P. Breast cancer screening: report to the
Health Ministers of England, Wales, Scotland &
Northern Ireland. London: HMSO, 1986.
2. Day N, McCann J, Camilleri-Ferrante C, Britton P,
Hurst G, Cush S, et al. Monitoring interval cancers
in the Breast Screening Programme: The
East Anglian experience. Quality Assurance
Management Group of East Anglian Breast
Screening Programme. J Med Screen 1995;2:1805.
3. Guidelines on the collection and use of breast
cancer data. Sheffield: NHSBSP, publication
number 26, 1993.
322